Tools


Sitemap

Sitemap

EANM 2017

Setting new standards with molecular imaging.

 

Plenary 1 – Sunday, October 22  
 Hall A, 10:00-11:15Theranostic Developments for Prostate Cancer (incl. Marie Curie Lecture)
Chairs: Dr. Kristoff Myulle, Prof. Francesco Giammarile
Prof. Jochen Walz (FR): Clinical Aspects
Prof. Ken Herrmann (DE): PSMA Imaging – Which Knife is the Sharpest?
Prof. Uwe Haberkorn (DE): Marie Curie Lecture: PSMA Labelled with Alfa-Emitters
 
Sunday, October 22, 2017  
 08:00 - 09:30CME 1-Physics-Challenges and Solutions for MR-Based Attenuation Correction of PET
 08:00 - 08:30Volkmar Schulz (Aachen): Introduction to MR-Based AC
 08:30 - 09:00Ninon Burgos (London): MR Based Attenuation Correction for Brain
 09:00 – 09:30Georg Schramm (Leuven): MR Based Attenuation Correction for the Body

 Monday, October 23, 2017

  
 08:00 - 09:30CME 5-Radiopharmacy/ Drug Development/ Radionuclide Therapy/ SNMMI-Theranostics and Companion Drugs
  08:00 - 08:30 08:00 - 08:30 Hans-Jürgen Wester (Munich): Theranostic Concepts, Exemplified on PSMA and CXCR4
  08:00 - 08:30 Karl Herholz (Manchester): Brain PET and SPECT in Patients with Fronto-Temporal Dementia
  08:00 - 09:30 Committee Symposium 2-Neuroimaging/Physics-PET/MR – Making it Clinical
  08:00 - 08:25 Claes Ladefoged (Copenhagen): Attenuation Correction - Is it Solved?
  08:25 - 08:45 Ian Law (Copenhagen): Brain Tumours
  08:30 - 09:00 Nicola Pavese (London): Brain PET and SPECT Imaging in Lewy Body Diseases
  08:30 - 09:00 Cathy Cutler (SNMMI, Upton): Development of Novel Theranostics
  08:45 - 09:05 Alexander Hammers (London): Epilepsy - What does Simultaneous PET-MR Achieve that PET+MR does not?
  09:05 - 09:30 Alexander Drzezga (Cologne): Dementia
  09:00 - 09:30 Jacques Barbet (Nantes): Pretargeting in the Context of Theranostics and Companion Diagnostics
  09:00 - 09:30 Javier Arbizu (Pamplona): Brain SPECT and PET in Tau-Related Parkinsonism
  11:30 - 13:00 Bone & Joint-Skeletal Scintigraphy Today – Accurate Diagnosis of Bone Disease with Therapeutic Impact
  11:30 - 11:50 Philipp Ritt (Erlangen): High Resolution SPECT/CT and Beyond
  11:30 - 13:00 CME 10-Neuroimaging-Brain PET and SPECT in Dementia – Beyond Alzheimer’s Disease
  11:50 - 12:10 Torsten Kuwert (Erlangen): SPECT/CT Quantification
  12:10 - 12:40 Zohar Keidar (Haifa): The End of Planar: Whole-Body SPECT as New Paradigm
  12:40 - 13:00 Gopinath Gnanasegaran (London): Top Ten Diagnoses Made Possible by SPECT/CT
  14:30 - 16:00 Do.More–Committee Symposium-Dosimetry-Validation of Quantitative Imaging, Dosimetry & Estimates of Uncertainty
  14:30 - 14:50 Frédéric Courbon (Toulouse): The Need for Dosimetry Validation - A Clinician’s
  14:50 - 15:10 Johan Ruben Gustafsson (Lund): The Use of Monte Carlo for Validation and Uncertainty Analysis
  15:10 - 15:30 Jonathan Gear (London): Propagation of Uncertainty Analysis for Absorbed Dose Calculations
  15:30 - 15:50 Andrew Robinson (Teddington): Validation of Calibration Protocols and the
  16:30 - 18:00 CME 8-Radionuclide Therapy/Radiopharmacy/Dosimetry-Clinical Trial Design for Radionuclide Therapy
  17:30 - 18:00 Rebecca Gregory (London): Dosimetry for Clinical Trials
 Wednesday, October 25, 2017   
  08:00 - 09:30 CME 13-Dosimetry/Radionuclide Therapy/Radiation Protection-Treatment Planning for Radionuclide Therapy, How Simple Can it Be? 
  08:45 - 9:05 Samer Ezzidin (Homburg): Are Traditional Fixed Activity Schedules Appropriate for Advancing in Personalised Medicine?
  09:05 – 9:20 Katarina Sjögreen Gleisner (Lund): Examples of Workflow and Requirements for Patient-Specific Dosimetry-Guided Treatments

 

Did this information help you?
Thank you for your response
We detected numbers and/or an '@' symbol in your comment. Are you trying to enter a phone number or email address so that we may contact you, please contact us via our email form instead.

Note: to get a direct personal response, please contact us via our email form.

Thank you